Apo-Valgan

Valsts: Jaunzēlande

Valoda: angļu

Klimata pārmaiņas: Medsafe (Medicines Safety Authority)

Aktīvā sastāvdaļa:

Valganciclovir hydrochloride 496.3mg equivalent to valganciclovir 450 mg

Pieejams no:

Apotex NZ Ltd

SNN (starptautisko nepatentēto nosaukumu):

Valganciclovir hydrochloride 496.3 mg (= valganciclovir 450 mg)

Deva:

450 mg

Zāļu forma:

Film coated tablet

Kompozīcija:

Active: Valganciclovir hydrochloride 496.3mg equivalent to valganciclovir 450 mg Excipient: Crospovidone Microcrystalline cellulose Opadry pink 80W540006 Purified water Stearic acid

Vienības iepakojumā:

Blister pack, Al/Al, 60 tablets

Klase:

Prescription

Receptes veids:

Prescription

Ražojis:

Apotex Pharmachem India Pvt. Ltd.

Ārstēšanas norādes:

Apo-Valgan is indicated for the treatment of cytomegalovirus (CMV) retinitis in acquired immunodeficiency syndrome (AIDS) patients.

Produktu pārskats:

Package - Contents - Shelf Life: Blister pack, Al/Al - 60 tablets - 24 months from date of manufacture stored at or below 25°C protect from light and moisture - Bottle, HDPE - 60 tablets - 24 months from date of manufacture stored at or below 25°C protect from light and moisture - Bottle, HDPE - 120 tablets - 24 months from date of manufacture stored at or below 25°C protect from light and moisture - Bottle, HDPE - 180 tablets - 24 months from date of manufacture stored at or below 25°C protect from light and moisture

Autorizācija datums:

2012-07-05